Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Growth Regulator mTORC2 Linked to Diabetes

14.05.2012
The signaling protein mTOR is a key regulator that controls cell growth. Dysfunction of mTOR increases not only the likelihood of developing cancer but also diabetes.
In the current issue of the journal «Cell Metabolism», Mike Hall and his team from the Biozentrum of the University of Basel describe how inhibition of mTOR signaling can impair carbohydrate metabolism and potentially lead to diabetes.

The protein mTOR regulates both cell growth and metabolism and thus plays a key role in the development of many disorders. In the cell, this regulatory protein is found in two structurally and functionally distinct multiprotein complexes called mTORC1 and mTORC2. mTORC2 is less well studied than mTORC1.
After the research group of Mike Hall from the Biozentrum of the University of Basel recently demonstrated how mTORC2 is activated in tumor cells, a new investigation by the same team has shed light on the role of mTORC2 in carbohydrate metabolism and in the development of diabetes.

Diabetes due to mTORC2 deficiency
In the healthy organism, insulin regulates blood glucose levels and activates the mTORC2 signaling pathway. Upon genetic inactivation of mTORC2 in the liver, blood glucose and insulin levels were elevated as soon as a few weeks after birth. In addition, the loss of mTORC2 led to insulin resistance. Consequently, liver cells could no longer respond to nutrients supplied via the diet and continued to produce new carbohydrates despite rising blood glucose levels.

The scientists also demonstrated how insulin resistance, originally affecting only the liver, spread to the whole body with the increasing age of the animals. The mice developed the typical symptoms of type 2 diabetes. The cell biologist Dr. Marion Cornu commented, "We were excited to see that the inhibition of mTORC2 in the liver caused an imbalance in carbohydrate metabolism not only in the liver but also in the the whole organism. This told us that mTORC2 in the liver controls metabolism of the whole body."

Cancer treatment with side effects
mTOR inhibitors currently being developed for use against tumor growth usually inhibit both mTOR complexes. Through the use of newer, more specific mTORC2 inhibitors doctors hope to be able to prevent uncontrolled growth of tumor cells without affecting healthy cells. The new findings of Hall and his team provide evidence that such cancer treatments must take into account the development of diabetes as a possible side effect.

Original article
Asami Hagiwara, Marion Cornu, Nadine Cybulski, Pazit Polak, Charles Betz, Francesca Trapani, Luigi Terracciano, Markus H. Heim, Markus A. Rüegg, Michael N. Hall
Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
Cell Metabolism, Volume 15, Issue 5, 725-738, 19 April 2012 | doi: 10.1016/j.cmet.2012.03.015

Media Contact
Prof. Dr. Michael N. Hall, Biozentrum of the University of Basel, Tel: +41 61 267 21 50, E-mail: m.hall@unibas.ch

Reto Caluori | idw
Further information:
http://www.unibas.ch
http://www.cell.com/cell-metabolism/abstract/S1550-4131%2812%2900135-0

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>